BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 2339999)

  • 1. Assessment of antacid characteristics of drugs containing a combination of aluminium and magnesium salts using the "artificial stomach" model.
    Vatier J; Vitre MT; Lionnet F; Poitevin C; Mignon M
    Arzneimittelforschung; 1990 Jan; 40(1):42-8. PubMed ID: 2339999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the antacid properties of Gelox in a dynamic milieu using the artificial stomach apparatus].
    Vatier J; Vitre MT; Lionnet F; Mignon M
    Therapie; 1989; 44(1):43-8. PubMed ID: 2734720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers.
    Vatier J; Ramdani A; Vitré MT; Mignon M
    Arzneimittelforschung; 1994 Apr; 44(4):514-8. PubMed ID: 8011006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antacid action of the aluminum cation: comparison of the in vitro effect of hydroxide and phosphate in open and closed systems].
    Vatier J; Lionnet F; Vitre MT
    Gastroenterol Clin Biol; 1987 Nov; 11(11):758-63. PubMed ID: 3428519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [pH gradient support and antacid action of gastroesophageal coating agents. In vitro pharmacologic study using a model of "the artificial stomach"].
    Vatier J; Vitre MT; Vallot T; Mignon M
    Gastroenterol Clin Biol; 1990; 14(5):414-22. PubMed ID: 2163935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new antacid, almagate.
    Beneyto JE; Fábregas JL; Moragues J; Spickett RG
    Arzneimittelforschung; 1984; 34(10A):1350-4. PubMed ID: 6439224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model of an 'artificial stomach' for assessing the characteristics of an antacid.
    Vatier J; Lionnet F; Vitré MT; Mignon M
    Aliment Pharmacol Ther; 1988 Oct; 2(5):461-70. PubMed ID: 2979268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An artificial stomach-duodenum model for the in-vitro evaluation of antacids.
    Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
    Aliment Pharmacol Ther; 1992 Aug; 6(4):447-58. PubMed ID: 1420737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro assessment of antacid efficacy using a computer-controlled 'artificial stomach-duodenum' model reproducing gastroduodenal flux regulation.
    Vatier J; Cai S; Célice-Pingaud C; Castela-Papin N; Mignon M; Farinotti R
    Therapie; 1996; 51(2):147-54. PubMed ID: 8763049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
    Lin MS; Sun P; Yu HY
    J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antacid and formula effects on gastric acidity in infants with gastroesophageal reflux.
    Sutphen JL; Dillard VL; Pipan ME
    Pediatrics; 1986 Jul; 78(1):55-7. PubMed ID: 3725503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aluminum hydroxide/magnesium hydroxide antacid and bismuth subsalicylate on gastric pH in horses.
    Clark CK; Merritt AM; Burrow JA; Steible CK
    J Am Vet Med Assoc; 1996 May; 208(10):1687-91. PubMed ID: 8641951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotelemetric comparison of two antacids using the Heidelberg capsule.
    Gómez Puch LM; Ríos Solans G; Muñoz y Fernandez JR
    Arzneimittelforschung; 1984; 34(10A):1378-80. PubMed ID: 6548925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro comparison of the antacid potencies of almagate in tablets and suspension with those of other commercially available antacid preparations.
    Prieto R; Martinez-Tobed A; Fábregas JL; Beneyto JE
    Arzneimittelforschung; 1984; 34(10A):1360-4. PubMed ID: 6548920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the antacid properties of almagate and aluminium hydroxide against pentagastrin-induced gastric secretion in healthy volunteers.
    Balanzó J; Guarner C; Vilardell F
    Arzneimittelforschung; 1984; 34(10A):1375-7. PubMed ID: 6439225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum and urine electrolyte behavior under therapeutic dosage of a potent magnesium and aluminum hydroxide containing antacid].
    Grünzig G; Lücker PW; Schnitker J
    Arzneimittelforschung; 1983; 33(2):258-62. PubMed ID: 6682667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy in vivo of almagate in neutralising histamine-induced acid secretion in a rat re-perfused stomach preparation.
    Llupiá J; Beckett PR; Lumachi B; Roberts DJ
    Arzneimittelforschung; 1984; 34(10A):1370-2. PubMed ID: 6548923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of proteolytic enzymes and polypeptides on the antacid activity of almagate and other antacids.
    Beneyto JE; Fábregas JL
    Arzneimittelforschung; 1984; 34(10A):1357-60. PubMed ID: 6391496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of magaldrate on circadian profile of gastric juice pH in medical intensive care patients (author's transl)].
    Dammann HG; Flashoff D; Müller P; Kather H; Simon B
    Dtsch Med Wochenschr; 1981 Oct; 106(44):1457-8. PubMed ID: 7297433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of neutralizing properties of antacid preparations. Part 3: Constant pH neutralization of hydrochloric acid by hydrotalcite.
    Kokot Z
    Pharmazie; 1988 Apr; 43(4):249-51. PubMed ID: 3413211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.